United Bank Of India To Get Rs 330 Crore Relief On RBI’s Provisioning Norms Breather
United Bank of India is poised to get a relief of Rs 330 crore from the Reserve Bank of India temporarily relaxing provisioning norms on accounts admitted under the National Company Law Tribunal for the March quarter earnings.
The bank had impending provision of Rs 250 crore to be made on stressed accounts, that it is now exempted following the central bank's temporary respite. Additionally, the lender will be writing back Rs 80 crore in its books, bringing the total relief tally to Rs 330 crore, said managing director Pawan Kumar Bajaj in a conversation with BloombergQuint today.
The RBI, last night, allowed banks to provide only up to 40 percent of secured loans against accounts undergoing insolvency proceedings under the NCLT. The earlier norm required bankers to provide a 50 percent provisioning against secured loans in the NCLT cases.
The central bank also asked banks to raise the minimum provisioning back to 50 percent by June 30. Commenting on this, Bajaj said that lower provisions in March quarter will not lead to higher provisions in the June quarter. “Recoveries from resolution of cases under the first list of NCLT will take care of provisions in the first quarter of the financial year 2018-19,” he added.
In June last year, the banking regulator had asked lenders to provide for 50 percent of all secured loans against NCLT accounts, and 100 percent of unsecured exposures. The provisioning requirement on unsecured loans would remain at 100 percent.
Watch the full conversation here:
Also Read: RBI Allows PNB To Spread Losses Over Four Quarters
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.